Approval · Notice of Compliance 5017 · 1995
DIFLUCAN: Notice of Compliance 5017
Issued September 22, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5017
- Date
- September 22, 1995
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: use of the drug in pediatric patients
- Therapeutic class
- Antifungal
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIFLUCAN | Not yet assigned | — |
Medicinal ingredients
- FLUCONAZOLE 100 MG per TAB
- FLUCONAZOLE 200 MG per TAB
- FLUCONAZOLE 10 MG per ML
- FLUCONAZOLE 40 MG per ML
- FLUCONAZOLE 2 MG per ML
- FLUCONAZOLE 50 MG per TAB